Fecal microbiota transplantation‐based treatment protocol for chronic insomnia disorder: A randomized, double‐blind, placebo‐controlled trial
OBJECTIVE: Chronic insomnia disorder is common and burdensome, and current treatments remain limited. We conducted a multicenter, randomized, double-blind, placebo-controlled trial to determine whether a fecal microbiota transplantation (FMT)-based treatment protocol improves sleep outcomes in adults with chronic insomnia disorder. METHODS: Participants were randomly assigned 1:1 to receive short-course antibiotic pretreatment followed by donor microbiota capsules (n = 40) or placebo capsules without antibiotic pretreatment (n = 40). Within each group, participants were further randomized to receive synbiotic supplementation or matched placebo for prespecified exploratory subgroup analyses. The primary outcome was polysomnography-measured sleep efficiency (SE) at 1 month after treatment. Secondary outcomes included other polysomnographic parameters, patient-reported sleep outcomes, and safety; microbiota analyses were exploratory. RESULTS: Compared with placebo, the FMT-based treatment protocol improved SE (adjusted between-group difference, 13.9 percentage points; 95% CI 7.29-20.41; p = 0.003) and reduced wake after sleep onset. Synbiotic assignment did not suggest meaningful differences in SE. Insomnia Severity Index and Pittsburgh Sleep Quality Index scores showed sustained improvement from 2 to 6 months. Treatment was well tolerated, with mild, self-limited adverse events and no serious adverse events. The intervention increased microbial richness and diversity and altered community structure; responders and non-responders showed similar posttreatment β-diversity change but differed in baseline microbiota composition. CONCLUSION: In adults with chronic insomnia disorder, an FMT-based treatment protocol incorporating antibiotic pretreatment improved objective sleep continuity and sustained subjective insomnia outcomes. Baseline microbial composition may contribute to treatment heterogeneity and merits further investigation.
Authors
- Xinyu Zhou (ORCID: https://orcid.org/0000-0003-1908-0357)
- Weifeng Mi (ORCID: https://orcid.org/0000-0003-2561-9785)
- Yanping Bao (ORCID: https://orcid.org/0000-0002-1881-0939)
- Teng Gao (ORCID: https://orcid.org/0000-0001-5825-6541)
- Sijing Chen (ORCID: https://orcid.org/0000-0001-8849-9202)
- Xiaoxing Liu (ORCID: https://orcid.org/0000-0001-7592-0483)
- M Vitiello
- Yixiao Fu (ORCID: https://orcid.org/0000-0002-2732-2865)
- Changzheng Wu (ORCID: https://orcid.org/0000-0002-4416-6358)
- Yongfeng Yang (ORCID: https://orcid.org/0000-0003-0358-0752)
- Zi Wang (ORCID: https://orcid.org/0000-0002-3953-0493)
- Yongxiang Wang (ORCID: https://orcid.org/0000-0002-8832-7301)
- Le Shi (ORCID: https://orcid.org/0000-0003-4827-4003)
- Keke Zhu (ORCID: https://orcid.org/0009-0007-6129-0039)
- l Zhi-Bing Lu
- Daomin Zhu
- Y F Yang
- Feng Geng
- Xinrong Li
- Keki Wen
- Mingming Zheng
- Xueqin Wang (ORCID: https://orcid.org/0000-0002-2056-196X)
- Jie Sun
Institutions
- Shanxi Medical University (CN)
- Chinese University of Hong Kong (HK)
- Anhui Medical University (CN)
- University of Washington (US)
- Peking University (CN)
- Beijing VDJBio (China) (CN)
- Henan Psychiatric Hospital (CN)
- Beijing Anding Hospital (CN)
- First Hospital of Shanxi Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Peking University Third Hospital (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
- Fourth Affiliated Hospital of Anhui Medical University (CN)
- Peking University Sixth Hospital (CN)
- Shandong First Medical University (CN)
- Henan Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Journal of Internal Medicine
- Published
- 2026-07-22
- DOI
- https://doi.org/10.1111/joim.70137
- Primary Topic
- Sleep and related disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00